Insider · CIK 0001188956

GARCIA PETER S

Reports to the SEC for 6 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001188956

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-11	DURECT CORPU Disposition from Tender	Director	UDisposition from Tender	−12.5K sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-09	DURECT CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,500 sh	$1.22	+$6,710	12,500
2025-09-09	DURECT CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,500 sh	—	—	0
2024-09-25	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2024-08-14	ALXOALX ONCOLOGY HOLDINGS INCF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−761 sh	$2.58	−$1,963.38	121,516
2024-06-28	ALXOALX ONCOLOGY HOLDINGS INCF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−1,789 sh	$6.03	−$10.8K	122,277
2024-06-13	ALXOALX ONCOLOGY HOLDINGS INCP Purchase	CHIEF FINANCIAL OFFICER	PPurchase	+12K sh	$8.53	+$102K	122,348
2024-06-13	ALXOALX ONCOLOGY HOLDINGS INCP Purchase	CHIEF FINANCIAL OFFICER	PPurchase	+12K sh	$8.53	+$102K	122,348
2024-02-14	ALXOALX ONCOLOGY HOLDINGS INCA Award	CHIEF FINANCIAL OFFICER	AAward	+25K sh	—	—	110,348
2024-02-14	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+80K sh	—	—	80,000
2023-12-29	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,893 sh	$15.04	−$28.5K	85,348
2023-07-25	ALXOALX ONCOLOGY HOLDINGS INCA Award	CHIEF FINANCIAL OFFICER	AAward	+32K sh	—	—	86,738
2023-07-25	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+101K sh	—	—	101,000
2023-06-30	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−887 sh	$7.34	−$6,510.58	54,738
2023-06-21	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2022-12-29	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−893 sh	$11.07	−$9,885.599	53,723
2022-08-05	ALXOALX ONCOLOGY HOLDINGS INCA Award	CHIEF FINANCIAL OFFICER	AAward	+29K sh	—	—	55,178
2022-08-05	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+95K sh	—	—	95,000
2022-06-15	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2022-02-07	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,637 sh	$4.08	+$27.1K	16,120
2022-02-07	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,363 sh	$4.81	+$40.2K	24,483
2022-02-07	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,637 sh	—	—	89,022
2022-02-07	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,363 sh	—	—	20,813
2021-12-13	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+70K sh	—	—	70,000
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,229 sh	$4.08	+$29.5K	16,560
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,851 sh	$54.33	−$155K	13,709
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,903 sh	$55.15	−$105K	11,806
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,437 sh	$56.09	−$80.6K	10,369
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−411 sh	$57.54	−$23.6K	9,958
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−438 sh	$58.30	−$25.5K	9,520
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−189 sh	$59.06	−$11.2K	9,331
2021-10-18	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,229 sh	—	—	60,468
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+11.3K sh	$4.08	+$46.3K	20,676
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,027 sh	$77.84	−$79.9K	19,649
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−7,199 sh	$78.61	−$566K	12,450
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,746 sh	$79.46	−$139K	10,704
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−273 sh	$80.22	−$21.9K	10,431
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,100 sh	$81.19	−$89.3K	9,331
2021-09-17	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−11.3K sh	—	—	67,697
2021-09-16	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,426 sh	$4.08	+$5,818.08	10,757
2021-09-16	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,426 sh	$80.43	−$115K	9,331
2021-09-16	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,426 sh	—	—	79,042
2021-08-23	ALXOALX ONCOLOGY HOLDINGS INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+60K sh	$4.08	+$245K	69,331
2021-08-23	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,593 sh	$70.86	−$113K	67,738
2021-08-23	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,497 sh	$72.03	−$252K	64,241
2021-08-23	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−18.1K sh	$72.66	−$1.31M	46,181
2021-08-23	ALXOALX ONCOLOGY HOLDINGS INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,008 sh	$73.57	−$295K	42,173

Recent filings

Accepted (ET)
Sep 124
GARCIA PETER S0000950170-25-114650
SEC(opens sec.gov)
Sep 114
GARCIA PETER S0000950170-25-114308
SEC(opens sec.gov)
Sep 274
GARCIA PETER S0000950170-24-110019
SEC(opens sec.gov)
Aug 164
GARCIA PETER S0001415889-24-021476
SEC(opens sec.gov)
Jul 24
GARCIA PETER S0001415889-24-018919
SEC(opens sec.gov)
Jun 244/A
GARCIA PETER S0001415889-24-017899
SEC(opens sec.gov)
Jun 174
GARCIA PETER S0001415889-24-017054
SEC(opens sec.gov)
Feb 164
GARCIA PETER S0001415889-24-004231
SEC(opens sec.gov)
Jan 34
GARCIA PETER S0001209191-24-000366
SEC(opens sec.gov)
Jul 274
GARCIA PETER S0001209191-23-043519
SEC(opens sec.gov)
Jul 54
GARCIA PETER S0001209191-23-041175
SEC(opens sec.gov)
Jun 234
GARCIA PETER S0001209191-23-039472
SEC(opens sec.gov)
Jan 34
GARCIA PETER S0001209191-23-000475
SEC(opens sec.gov)
Aug 94
GARCIA PETER S0001209191-22-045056
SEC(opens sec.gov)

Companies

Address

3830 MONTE VILLA PARKWAY

BOTHELL, WA, 98021